The National Medical Products Administration approved the listing of Anrikfen Injection.

Recently, the National Medical Products Administration approved Haisco Pharmaceutical Group Co., Ltd.'s application for the Class 1 innovative drug Arrikfen injection, which is used for treating mild to moderate pain after abdominal surgery. The listing of this drug provides patients with a new treatment option.